Edwards Lifesciences (EW) Competitors $76.73 +0.48 (+0.63%) As of 11:38 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EW vs. HSIC, AMN, ISRG, SYK, BSX, MDT, BDX, IDXX, RMD, and DXCMShould you be buying Edwards Lifesciences stock or one of its competitors? The main competitors of Edwards Lifesciences include Henry Schein (HSIC), AMN Healthcare Services (AMN), Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), ResMed (RMD), and DexCom (DXCM). These companies are all part of the "medical" sector. Edwards Lifesciences vs. Its Competitors Henry Schein AMN Healthcare Services Intuitive Surgical Stryker Boston Scientific Medtronic Becton, Dickinson and Company IDEXX Laboratories ResMed DexCom Edwards Lifesciences (NYSE:EW) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends. Which has higher earnings and valuation, EW or HSIC? Edwards Lifesciences has higher earnings, but lower revenue than Henry Schein. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdwards Lifesciences$5.44B8.28$4.17B$6.9511.04Henry Schein$12.67B0.63$390M$3.1021.28 Is EW or HSIC more profitable? Edwards Lifesciences has a net margin of 72.96% compared to Henry Schein's net margin of 3.05%. Edwards Lifesciences' return on equity of 15.01% beat Henry Schein's return on equity.Company Net Margins Return on Equity Return on Assets Edwards Lifesciences72.96% 15.01% 11.56% Henry Schein 3.05%14.36%5.52% Do institutionals and insiders hold more shares of EW or HSIC? 79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 0.3% of Edwards Lifesciences shares are owned by insiders. Comparatively, 1.1% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media favor EW or HSIC? In the previous week, Edwards Lifesciences had 1 more articles in the media than Henry Schein. MarketBeat recorded 13 mentions for Edwards Lifesciences and 12 mentions for Henry Schein. Edwards Lifesciences' average media sentiment score of 1.19 beat Henry Schein's score of 0.86 indicating that Edwards Lifesciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 7 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Which has more volatility and risk, EW or HSIC? Edwards Lifesciences has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Do analysts rate EW or HSIC? Edwards Lifesciences presently has a consensus price target of $86.61, indicating a potential upside of 12.88%. Henry Schein has a consensus price target of $76.67, indicating a potential upside of 16.22%. Given Henry Schein's higher probable upside, analysts plainly believe Henry Schein is more favorable than Edwards Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edwards Lifesciences 1 Sell rating(s) 8 Hold rating(s) 11 Buy rating(s) 3 Strong Buy rating(s) 2.70Henry Schein 0 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.42 SummaryEdwards Lifesciences beats Henry Schein on 12 of the 17 factors compared between the two stocks. Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EW vs. The Competition Export to ExcelMetricEdwards LifesciencesMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$45.04B$6.56B$5.71B$21.57BDividend YieldN/A1.25%5.78%3.56%P/E Ratio11.0426.1976.0329.56Price / Sales8.28197.46552.4960.49Price / Cash27.9321.7425.6318.12Price / Book4.505.0512.864.63Net Income$4.17B$178.07M$3.30B$1.00B7 Day Performance3.97%-0.17%1.05%-0.45%1 Month Performance-5.83%5.21%4.45%2.12%1 Year Performance15.24%22.14%67.46%12.23% Edwards Lifesciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EWEdwards Lifesciences4.6774 of 5 stars$76.73+0.6%$86.61+12.9%+14.7%$45.04B$5.44B11.0415,800Positive NewsAnalyst DowngradeAnalyst RevisionHSICHenry Schein3.8904 of 5 stars$67.92+0.1%$76.67+12.9%-9.8%$8.24B$12.67B21.9125,000AMNAMN Healthcare Services4.4724 of 5 stars$19.11+2.1%$23.25+21.7%-55.7%$732.30M$2.98B-2.462,968ISRGIntuitive Surgical4.9587 of 5 stars$444.55+1.3%$595.95+34.1%-7.9%$159.36B$9.15B62.0015,638Positive NewsAnalyst DowngradeSYKStryker4.9779 of 5 stars$378.70+0.5%$430.33+13.6%+2.4%$144.78B$22.60B50.1653,000Positive NewsAnalyst DowngradeBSXBoston Scientific4.8667 of 5 stars$96.91-0.9%$118.04+21.8%+17.8%$143.60B$16.75B57.6953,000Positive NewsAnalyst ForecastMDTMedtronic4.9551 of 5 stars$94.69-0.4%$102.27+8.0%+5.6%$121.45B$33.54B26.0895,000Positive NewsEx-DividendBDXBecton, Dickinson and Company4.9786 of 5 stars$186.74-0.2%$213.30+14.2%-23.6%$53.53B$20.18B33.5974,000Positive NewsIDXXIDEXX Laboratories4.2118 of 5 stars$644.10-1.8%$649.44+0.8%+23.5%$51.53B$3.90B53.6311,000Positive NewsAnalyst DowngradeRMDResMed4.7658 of 5 stars$274.59+0.5%$292.00+6.3%+13.2%$40.20B$5.15B28.8710,600Positive NewsDXCMDexCom4.9499 of 5 stars$69.51+3.1%$99.89+43.7%-0.3%$27.26B$4.03B48.2710,300Analyst ForecastHigh Trading Volume Related Companies and Tools Related Companies Henry Schein Alternatives AMN Healthcare Services Alternatives Intuitive Surgical Alternatives Stryker Alternatives Boston Scientific Alternatives Medtronic Alternatives Becton, Dickinson and Company Alternatives IDEXX Laboratories Alternatives ResMed Alternatives DexCom Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EW) was last updated on 9/29/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EW Stock Alerts